Arabic Arabic English English French French German German
dark

Momordica charantia: a review of Its effects on metabolic diseases and mechanisms of action.

PMID: 

J Med Food. 2021 Mar 17. Epub 2021 Mar 17. PMID: 33733863

Abstract Title: 

A Review of Its Effects on Metabolic Diseases and Mechanisms of Action.

Abstract: 

The global rise in the prevalence of metabolic diseases such as diabetes, obesity, and dyslipidemia is a serious public health issue. The search for safe and effective complementary and alternative therapies to treat metabolic disorders is a key field of research.(MC) is a tropical and subtropical vine of the Cucurbitaceae family used as a medicinal plant since ancient times. Although MC has been widely studied for its hypoglycemic potential, hypolipidemic and antiobesity effects have also been reported in preclinical studies and clinical trials. This study aims to review the metabolic effects of MC reported in clinical trials as well as its mechanisms of action.

read more

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Momordica charantia induces non-apoptotic cell death in human MDA-MB-436 breast and A549 lung cancer cells.

Next Post

Anti-inflammatory, antidiabetic properties and in silico modeling of cucurbitane-type triterpene glycosides from fruits of an Indian cultivar of Momordica charantia.

Related Posts
Total
0
Share